Cigna Corp. buy melinda
Start price
01.09.17
/
50%
€165.16
Target price
27.10.17
€180.40
Performance (%)
9.31%
End price
27.10.17
€180.54
Summary
This prediction ended on 27.10.17 with a price of €180.54. With a performance of 9.31%, the BUY prediction by melinda for Cigna Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cigna Corp. | 1.578% | 1.578% | 45.563% | 61.511% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by melinda for this prediction
In the thread Cigna Corp. diskutieren
Mammographie
Release Zusammenfassung
Nach der jüngsten Marktstudie von Technavio, die Mammographie Markt in den USA wird voraussichtlich bei einer CAGR von fast 7% bis 2021 wachsen.